EE209 Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment in Adult Patients Following Complete Resection and Platinum-Based Chemotherapy with Non-Small Cell Lung Cancer (NSCLC) in Finland
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.458
https://www.valueinhealthjournal.com/article/S1098-3015(22)02662-6/fulltext
Title :
EE209 Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment in Adult Patients Following Complete Resection and Platinum-Based Chemotherapy with Non-Small Cell Lung Cancer (NSCLC) in Finland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02662-6&doi=10.1016/j.jval.2022.09.458
First page :
Section Title :
Open access? :
No
Section Order :
12267